← FDA Drug Approvals (Drugs@FDA)
PROGESTERONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2012-02-29
Drug application
- FDA Application #
ANDA202121- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PROGESTERONE
- Generic name
- Progesterone
- Active ingredients
- PROGESTERONE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS
- First approval
- 2012-02-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown